Researchers are exploring the role of peroxisome proliferator-activated receptors in primary biliary cholangitis, a liver disease. Studies are investigating molecular mechanisms and potential therapeutic targets, including the use of agonists and the impact on bile acid metabolism and inflammation. The condition's complex immunological aspects and overlap with other diseases are also being examined to identify new treatment strategies.